What is Minimally Invasive Vascular?
Minimally Invasive Vascular operates at the intersection of advanced clinical diagnostics and specialized outpatient care. The company provides high-precision vascular interventions designed to improve patient outcomes while reducing the reliance on traditional hospital-based surgical environments. By focusing on minimally invasive techniques, the organization addresses a critical market need for efficient, cost-effective, and patient-centric vascular health solutions. Their market position is defined by a commitment to technological integration and clinical excellence, allowing them to scale their diagnostic capabilities across regional healthcare networks.
How much funding has Minimally Invasive Vascular raised?
Minimally Invasive Vascular has raised a total of $434K across 2 funding rounds:
Debt
$134K
Debt
$300K
Debt (2021): $134K with participation from PPP
Debt (2025): $300K led by Lendistry SBLC
Key Investors in Minimally Invasive Vascular
Lendistry SBLC
A mission-driven fintech lender specializing in providing capital to small and medium-sized businesses to foster economic growth.
PPP
Public-Private Partnership
What's next for Minimally Invasive Vascular?
With the recent influx of capital, Minimally Invasive Vascular is positioned to accelerate its strategic growth initiatives. The late-stage nature of this financing suggests a focus on operational scaling, potential facility expansion, and the integration of next-generation diagnostic hardware. As the company navigates the complexities of the outpatient vascular market, the management team will likely prioritize the optimization of patient throughput and the enhancement of clinical service lines. This strategic deployment of resources is expected to solidify their competitive advantage, ensuring long-term sustainability and continued leadership in the specialized vascular care landscape.
See full Minimally Invasive Vascular company page
